Fresenius Medical Care AG & Co. KGaA
FMS | NYSE
$22.28
+$0.08 (+0.36%)
Sep 21, 2026, 1:37 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 19.63B | 19.34B | 19.45B | 19.4B | 17.62B | 17.86B |
Cost of Revenue | 14.6B | 14.58B | 14.53B | 14.5B | 12.85B | 12.32B |
Gross Profit | 5.03B | 4.76B | 4.93B | 4.89B | 4.77B | 5.54B |
Operating Income | 1.83B | 1.47B | 1.37B | 1.51B | 1.85B | 2.3B |
Interest Income | 69.61M | 71.58M | 88.22M | 67.66M | 73.17M | 41.96M |
Pretax Income | 1.51B | 1.06B | 1.03B | 1.22B | 1.57B | 1.94B |
Net Income | 978.37M | 537.91M | 499M | 673.41M | 969.31M | 1.16B |
Selling & General & Admin | 3.03B | 3.14B | 3.2B | 3.17B | 2.77B | 3.13B |
Research & Development | 157.98M | 183.49M | 231.97M | 228.62M | 220.78M | 193.77M |
Other Expenses | 11.4M | -37.04M | 127.26M | -17.06M | -72.87M | -94.52M |
Operating Expenses | 3.2B | 3.29B | 3.56B | 3.38B | 2.92B | 3.23B |
Interest Expense | 384.41M | 407.04M | 424.64M | 360.14M | 353.6M | 409.98M |
Selling & Marketing Expenses | 618.14M | 660.43M | 706.4M | 800.88M | n/a | n/a |
Cost & Expenses | 17.8B | 17.87B | 18.08B | 17.89B | 15.77B | 15.55B |
Income Tax Expense | 320.97M | 316.06M | 300.56M | 324.95M | 352.83M | 500.56M |
Shares Outstanding (Basic) | 582.38M | 587.88M | 587.06M | 1.17B | 1.17B | 888.24M |
Shares Outstanding (Diluted) | 582.38M | 586.83M | 586.83M | 1.17B | 1.17B | 887.33M |
EPS (Basic) | 1.68 | 0.92 | 0.85 | 0.57 | 0.83 | 1.31 |
EPS (Diluted) | 1.68 | 0.92 | 0.85 | 0.57 | 0.83 | 1.31 |
EBITDA | 3.4B | 3.21B | 3.21B | 3.42B | 3.55B | 4.13B |
EBIT | 1.9B | 1.46B | 1.46B | 1.58B | 1.93B | 2.35B |
Depreciation & Amortization | 1.5B | 1.74B | 1.75B | 1.84B | 1.62B | 1.79B |
Add to Watchlist
Select watchlists to add or remove FMS